secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2025-04-10T23:59:59+00:00
Accession:  0001005286-25-000061
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Lifecore Biomedical shareholders approve issuance of shares beyond 19.99% threshold
--------------------------------------------------------------------------------

- At April 10, 2025 special meeting, stockholders approved the Issuance Proposal, allowing issuance of common stock underlying Series A Preferred Stock in excess of 19.99% of outstanding common shares.
- Votes on Issuance Proposal: 24,098,218 For, 444,639 Against, 33,281 Abstain.
- Adjournment Proposal was also approved (28,882,501 For) but not needed since Issuance Proposal passed.
- The approval relates to the Securities Purchase Agreement dated January 9, 2023, with named investors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528625000061/0001005286-25-000061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528625000061/lndc-20250410.htm
  HTML page:      https://secwatch.observer/filing/0001005286-25-000061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer